1887

Abstract

Folding and assembly into complexes of some viral glycoproteins are exquisitely sensitive to endoplasmic reticulum (ER) -glucosidase inhibition, which prevents the trimming of glucose from -linked glycans. Derivatives of deoxynojirimycin (DNJ) iminosugars, which are potent -glucosidase inhibitors, were shown to have antiviral activity against bovine viral diarrhea virus, a pestivirus related to hepatitis C virus (HCV). The aim of this study was to determine whether these inhibitors would affect HCV infectivity and to provide novel insights on their mechanism of action. The overall antiviral activity of glucosidase inhibitors was shown by using the two most relevant models currently available: the cell-culture model enabling complete replication of the HCV JFH1 strain in Huh7.5 cells, and infectious HCV pseudotyped particles (HCVpp) produced in HEK-293T cells that display functional E1–E2 glycoprotein complexes. By using the latter model, it is shown that the inhibition of -glucosidases by iminosugars results in the misfolding and misassembly of HCV glycoprotein pre-budding complexes. This inhibition of the assembly of E1–E2 in the ER of transfected HEK-293T cells leads to a reduction in the incorporation of E1–E2 complexes into HCVpp. More importantly, it is demonstrated that the infectivity of HCVpp that are released under treatment is reduced and that this reduction in infectivity is due to the incorporation of misfolded envelope glycoproteins in secreted particles. These properties suggest the potential usefulness of DNJ derivatives in combating HCV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82465-0
2007-04-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/4/1133.html?itemId=/content/journal/jgv/10.1099/vir.0.82465-0&mimeType=html&fmt=ahah

References

  1. Bartosch, B. & Cosset, F. L. ( 2006; ). Cell entry of hepatitis C virus. Virology 348, 1–12.[CrossRef]
    [Google Scholar]
  2. Bartosch, B., Dubuisson, J. & Cosset, F. L. ( 2003; ). Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes. J Exp Med 197, 633–642.[CrossRef]
    [Google Scholar]
  3. Bischoff, J., Liscum, L. & Kornfeld, R. ( 1986; ). The use of 1-deoxymannojirimycin to evaluate the role of various alpha-mannosidases in oligosaccharide processing in intact cells. J Biol Chem 261, 4766–4774.
    [Google Scholar]
  4. Braakman, I. & van Anken, E. ( 2000; ). Folding of viral envelope glycoproteins in the endoplasmic reticulum. Traffic 1, 533–539.[CrossRef]
    [Google Scholar]
  5. Branza-Nichita, N., Durantel, D., Carrouee-Durantel, S., Dwek, R. A. & Zitzmann, N. ( 2001; ). Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1–E2 heterodimers. J Virol 75, 3527–3536.[CrossRef]
    [Google Scholar]
  6. Branza-Nichita, N., Lazar, C., Dwek, R. A. & Zitzmann, N. ( 2004; ). Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns). Biochem Biophys Res Commun 319, 655–662.[CrossRef]
    [Google Scholar]
  7. Callens, N., Ciczora, Y., Bartosch, B., Vu-Dac, N., Cosset, F. L., Pawlotsky, J. M., Penin, F. & Dubuisson, J. ( 2005; ). Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 79, 15331–15341.[CrossRef]
    [Google Scholar]
  8. Choukhi, A., Pillez, A., Drobecq, H., Sergheraert, C., Wychowski, C. & Dubuisson, J. ( 1999; ). Characterization of aggregates of hepatitis C virus glycoproteins. J Gen Virol 80, 3099–3107.
    [Google Scholar]
  9. Cocquerel, L., Meunier, J. C., Pillez, A., Wychowski, C. & Dubuisson, J. ( 1998; ). A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72, 2183–2191.
    [Google Scholar]
  10. Cocquerel, L., Meunier, J. C., Op de Beeck, A., Bonte, D., Wychowski, C. & Dubuisson, J. ( 2001; ). Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2. J Gen Virol 82, 1629–1635.
    [Google Scholar]
  11. Cocquerel, L., Kuo, C. C., Dubuisson, J. & Levy, S. ( 2003; ). CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 77, 10677–10683.[CrossRef]
    [Google Scholar]
  12. Davis, G. L., Albright, J. E., Cook, S. F. & Rosenberg, D. M. ( 2003; ). Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 9, 331–338.[CrossRef]
    [Google Scholar]
  13. Dubuisson, J. ( 2000; ). Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr Top Microbiol Immunol 242, 135–148.
    [Google Scholar]
  14. Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell, D. G. & Rice, C. M. ( 1994; ). Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68, 6147–6160.
    [Google Scholar]
  15. Durantel, D., Branza-Nichita, N., Carrouee-Durantel, S., Butters, T. D., Dwek, R. A. & Zitzmann, N. ( 2001; ). Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J Virol 75, 8987–8998.[CrossRef]
    [Google Scholar]
  16. Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G. R., Borrow, P. & McKeating, J. A. ( 2000; ). Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J Virol 74, 702–709.[CrossRef]
    [Google Scholar]
  17. Flint, M., Logvinoff, C., Rice, C. M. & McKeating, J. A. ( 2004; ). Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J Virol 78, 6875–6882.[CrossRef]
    [Google Scholar]
  18. Foster, G. R. ( 2004; ). Past, present, and future hepatitis C treatments. Semin Liver Dis 24, (Suppl. 2), 97–104.[CrossRef]
    [Google Scholar]
  19. Goffard, A., Callens, N., Bartosch, B., Wychowski, C., Cosset, F. L., Montpellier, C. & Dubuisson, J. ( 2005; ). Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 79, 8400–8409.[CrossRef]
    [Google Scholar]
  20. Hammond, C. & Helenius, A. ( 1994; ). Folding of VSV G protein: sequential interaction with BiP and calnexin. Science 266, 456–458.[CrossRef]
    [Google Scholar]
  21. Helenius, A. & Aebi, M. ( 2004; ). Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73, 1019–1049.[CrossRef]
    [Google Scholar]
  22. Iqbal, M., Flick-Smith, H. & McCauley, J. W. ( 2000; ). Interactions of bovine viral diarrhoea virus glycoprotein Erns with cell surface glycosaminoglycans. J Gen Virol 81, 451–459.
    [Google Scholar]
  23. Johnson, V. A., Brun-Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., Pillay, D., Schapiro, J., Telenti, A. & Richman, D. ( 2005; ). Update of the drug resistance mutations in HIV-1: 2005. Top HIV Med 13, 51–57.
    [Google Scholar]
  24. Liang, T. J. & Heller, T. ( 2004; ). Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127, S62–S71.[CrossRef]
    [Google Scholar]
  25. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors ( 2005; ). Complete replication of hepatitis C virus in cell culture. Science 309, 623–626.[CrossRef]
    [Google Scholar]
  26. Locarnini, S., Hatzakis, A., Heathcote, J., Keeffe, E. B., Liang, T. J., Mutimer, D., Pawlotsky, J. M. & Zoulim, F. ( 2004; ). Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther 9, 679–693.
    [Google Scholar]
  27. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. ( 1999; ). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113.[CrossRef]
    [Google Scholar]
  28. Lozach, P. Y., Amara, A., Bartosch, B., Virelizier, J. L., Arenzana-Seisdedos, F., Cosset, F. L. & Altmeyer, R. ( 2004; ). C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 279, 32035–32045.[CrossRef]
    [Google Scholar]
  29. Op De Beeck, A., Voisset, C., Bartosch, B., Ciczora, Y., Cocquerel, L., Keck, Z., Foung, S., Cosset, F. L. & Dubuisson, J. ( 2004; ). Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78, 2994–3002.[CrossRef]
    [Google Scholar]
  30. Pawlotsky, J. M. ( 2005; ). Current and future concepts in hepatitis C therapy. Semin Liver Dis 25, 72–83.[CrossRef]
    [Google Scholar]
  31. Pohlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. J., Lin, G., Granelli-Piperno, A., Doms, R. W., Rice, C. M. & McKeating, J. A. ( 2003; ). Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77, 4070–4080.[CrossRef]
    [Google Scholar]
  32. Seeff, L. B. ( 2002; ). Natural history of chronic hepatitis C. Hepatology 36, S35–S46.[CrossRef]
    [Google Scholar]
  33. Voisset, C., Callens, N., Blanchard, E., Op De Beeck, A., Dubuisson, J. & Vu-Dac, N. ( 2005; ). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280, 7793–7799.[CrossRef]
    [Google Scholar]
  34. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G. & other authors ( 2005; ). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791–796.[CrossRef]
    [Google Scholar]
  35. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T. & Chisari, F. V. ( 2005; ). Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294–9299.[CrossRef]
    [Google Scholar]
  36. Zitzmann, N., Mehta, A. S., Carrouee, S., Butters, T. D., Platt, F. M., McCauley, J., Blumberg, B. S., Dwek, R. A. & Block, T. M. ( 1999; ). Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A 96, 11878–11882.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82465-0
Loading
/content/journal/jgv/10.1099/vir.0.82465-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error